SCHEMBL2864256

SCHEMBL2864256

O=C(O)c1ccc2[nH]nc(-c3ccccc3F)c2c1

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 6/20 0.52
MAPK1 P28482 7/20 0.52
MAPK6 Q16659 4/20 0.52
MAPKAPK3 Q16644 3/20 0.52
CSNK2A2 P19784 1/20 0.51
CSNK2B P67870 1/20 0.51
PIM1 P11309 6/20 0.50
ITK Q08881 1/20 0.49
MAPK3 P27361 2/20 0.46
MAP4K1 Q92918 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2857478 0.85 MAP2K4 (0.52) MAP2K4MAPK1PIM1MAPK3MAP4K1
SCHEMBL31172491 0.84 ITK (0.46) MAP2K4MAPK1MAPK6MAPKAPK3CSNK2A2
SCHEMBL16981785 0.84 MAP2K4 (0.63) MAP2K4MAPK1MAPK6MAPKAPK3ITK
SCHEMBL2866791 0.83 MAP2K4 (0.69) MAP2K4MAPK1MAPK6MAPKAPK3ITK
SCHEMBL6502471 0.82 MAPK1 (0.55) MAPK1MAPK3MAP4K1
SCHEMBL2868586 0.81 MAPK1 (0.51) MAP2K4MAPK1MAPK6MAPKAPK3ITK
SCHEMBL2862381 0.79 MAP2K4 (0.70) MAP2K4MAPK1MAPK6MAPKAPK3CSNK2A2
SCHEMBL7092987 0.79 FFAR1 (0.58) MAPK1PIM1MAPK3
SCHEMBL2858476 0.78 MAP2K4 (0.68) MAP2K4MAPK1MAPK6MAPKAPK3CSNK2A2
SCHEMBL2864569 0.78 MAP2K4 (0.52) MAP2K4MAPK1MAPK6MAPKAPK3ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPK6 24/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885MAPK1 1/4885MAPK6 5/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPK6 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.